Maheshi Ramasamy
Senior Clinical Researcher
Dr Maheshi Ramasamy obtained her medical degree at Christ's College, University of Cambridge. She trained in Infectious Diseases and General Internal Medicine and obtained a DPhil at Wadham College, University of Oxford investigating B cell responses to conjugate and polysaccharide meningococcal vaccines.
As a Principal Investigator at the Oxford Vaccine Group, she leads on adult clinical vaccine trials and her research interest is in adaptive immune responses to vaccines.
She is a Consultant Physician at the Oxford University Hospitals NHS Foundation Trust and is an Honorary Senior Clinical Lecturer at the University of Oxford.
Recent publications
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial
Journal article
EWER K. et al, (2021), Lancet HIV
-
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Journal article
Voysey M. et al, (2021), Lancet, 397, 881 - 891
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Journal article
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
-
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.
Journal article
O'Connor D. et al, (2017), Genome Med, 9, 11 - 11